Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02446704 |
|
Recruitment Status : Unknown
Verified January 2022 by Zofia Piotrowska, Massachusetts General Hospital.
Recruitment status was: Active, not recruiting
First Posted : May 18, 2015
Last Update Posted : February 7, 2022
|
Sponsor:
Zofia Piotrowska
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Zofia Piotrowska, Massachusetts General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 2022 |
| Estimated Study Completion Date : | December 2023 |